HRP20050667A2 - Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof - Google Patents
Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereofInfo
- Publication number
- HRP20050667A2 HRP20050667A2 HR20050667A HRP20050667A HRP20050667A2 HR P20050667 A2 HRP20050667 A2 HR P20050667A2 HR 20050667 A HR20050667 A HR 20050667A HR P20050667 A HRP20050667 A HR P20050667A HR P20050667 A2 HRP20050667 A2 HR P20050667A2
- Authority
- HR
- Croatia
- Prior art keywords
- corbonyl
- production
- substituted acyl
- urea derivatives
- amino substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/48—Y being a hydrogen or a carbon atom
- C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10302452A DE10302452B4 (de) | 2003-01-23 | 2003-01-23 | Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
| PCT/EP2004/000041 WO2004065356A1 (de) | 2003-01-23 | 2004-01-07 | Carbonylamino-substituierte acyl-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20050667A2 true HRP20050667A2 (en) | 2006-09-30 |
Family
ID=32694928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20050667A HRP20050667A2 (en) | 2003-01-23 | 2004-01-07 | Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1590322B1 (https=) |
| JP (1) | JP4557963B2 (https=) |
| KR (1) | KR20050104351A (https=) |
| CN (1) | CN1798730A (https=) |
| AT (1) | ATE443697T1 (https=) |
| AU (1) | AU2004205352A1 (https=) |
| BR (1) | BRPI0406840A (https=) |
| CA (1) | CA2513286A1 (https=) |
| CO (1) | CO5690542A2 (https=) |
| DE (2) | DE10302452B4 (https=) |
| HR (1) | HRP20050667A2 (https=) |
| MA (1) | MA27649A1 (https=) |
| MX (1) | MXPA05007515A (https=) |
| NO (1) | NO20053876L (https=) |
| PL (1) | PL376456A1 (https=) |
| RU (1) | RU2005126606A (https=) |
| WO (1) | WO2004065356A1 (https=) |
| ZA (1) | ZA200504647B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5385605B2 (ja) * | 2005-03-11 | 2014-01-08 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ａｔｐ結合カセットトランスポーターのモジュレーター |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| WO2009081892A1 (ja) * | 2007-12-25 | 2009-07-02 | Kissei Pharmaceutical Co., Ltd. | 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途 |
| EP2543660A4 (en) | 2010-03-04 | 2014-04-30 | Ajinomoto Kk | PROPHYLACTIC OR THERAPEUTIC ACTIVE AGAINST DIABETES OR ADIPOSITAS |
| GB201223308D0 (en) | 2012-12-21 | 2013-02-06 | Univ Sunderland | Enzyme inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH508019A (de) * | 1968-12-12 | 1971-05-31 | Ciba Geigy Ag | Verfahren zur Herstellung neuer Azofarbstoffpigmente |
| EP0116729B1 (en) * | 1983-01-24 | 1988-10-12 | Duphar International Research B.V | Benzoylurea compounds and pesticidal compositions comprisingsame |
| AU601145B2 (en) * | 1985-03-01 | 1990-09-06 | Duphar International Research B.V. | Benzoyl urea derivatives having anti-tumor activity |
| EP0324521A3 (en) * | 1988-01-11 | 1991-11-27 | Duphar International Research B.V | Method of treating haematologic diseases and pharmaceutical compositions to be used therefor |
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| WO1999046236A1 (en) * | 1998-03-12 | 1999-09-16 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
| CA2338121A1 (en) * | 1998-08-04 | 2000-02-17 | Astrazeneca Ab | Amide derivatives useful as inhibitors of the production of cytokines |
| GB0001662D0 (en) * | 1999-02-06 | 2000-03-15 | Zeneca Ltd | Pharmaceutical compositions |
| TR200401029T4 (tr) * | 2000-06-09 | 2004-06-21 | Aventis Pharma Deutschland Gmbh | Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları |
| PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| DE10225635C1 (de) * | 2002-06-07 | 2003-12-24 | Aventis Pharma Gmbh | N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
-
2003
- 2003-01-23 DE DE10302452A patent/DE10302452B4/de not_active Expired - Fee Related
-
2004
- 2004-01-07 CA CA002513286A patent/CA2513286A1/en not_active Abandoned
- 2004-01-07 WO PCT/EP2004/000041 patent/WO2004065356A1/de not_active Ceased
- 2004-01-07 MX MXPA05007515A patent/MXPA05007515A/es not_active Application Discontinuation
- 2004-01-07 EP EP04700448A patent/EP1590322B1/de not_active Expired - Lifetime
- 2004-01-07 RU RU2005126606/04A patent/RU2005126606A/ru not_active Application Discontinuation
- 2004-01-07 PL PL04376456A patent/PL376456A1/xx not_active Application Discontinuation
- 2004-01-07 DE DE502004010108T patent/DE502004010108D1/de not_active Expired - Lifetime
- 2004-01-07 AU AU2004205352A patent/AU2004205352A1/en not_active Abandoned
- 2004-01-07 JP JP2006500523A patent/JP4557963B2/ja not_active Expired - Fee Related
- 2004-01-07 CN CNA200480002674XA patent/CN1798730A/zh active Pending
- 2004-01-07 AT AT04700448T patent/ATE443697T1/de not_active IP Right Cessation
- 2004-01-07 KR KR1020057013500A patent/KR20050104351A/ko not_active Withdrawn
- 2004-01-07 BR BR0406840-8A patent/BRPI0406840A/pt not_active IP Right Cessation
- 2004-01-07 HR HR20050667A patent/HRP20050667A2/xx not_active Application Discontinuation
-
2005
- 2005-06-07 ZA ZA200504647A patent/ZA200504647B/en unknown
- 2005-07-21 CO CO05071890A patent/CO5690542A2/es not_active Application Discontinuation
- 2005-07-22 MA MA28408A patent/MA27649A1/fr unknown
- 2005-08-18 NO NO20053876A patent/NO20053876L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE10302452A1 (de) | 2004-08-12 |
| WO2004065356A1 (de) | 2004-08-05 |
| MXPA05007515A (es) | 2006-01-27 |
| JP4557963B2 (ja) | 2010-10-06 |
| DE10302452B4 (de) | 2005-02-24 |
| MA27649A1 (fr) | 2005-12-01 |
| CN1798730A (zh) | 2006-07-05 |
| NO20053876D0 (no) | 2005-08-18 |
| EP1590322A1 (de) | 2005-11-02 |
| ZA200504647B (en) | 2006-04-26 |
| ATE443697T1 (de) | 2009-10-15 |
| CA2513286A1 (en) | 2004-08-05 |
| RU2005126606A (ru) | 2006-01-20 |
| BRPI0406840A (pt) | 2005-12-13 |
| PL376456A1 (en) | 2005-12-27 |
| JP2006516971A (ja) | 2006-07-13 |
| AU2004205352A1 (en) | 2004-08-05 |
| EP1590322B1 (de) | 2009-09-23 |
| DE502004010108D1 (de) | 2009-11-05 |
| KR20050104351A (ko) | 2005-11-02 |
| NO20053876L (no) | 2005-10-12 |
| CO5690542A2 (es) | 2006-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20050532A2 (en) | Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof | |
| HRP20050531B1 (hr) | Novi aromatski derivati fluorglikozida, lijek koji sadrži te spojeve i njihova upotreba | |
| YU45403A (sh) | Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida | |
| TNSN05194A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
| HRP20050711A2 (en) | NITROGEN-SUBSTITUTED HEXAHYDROPYRAZINO[1,2-a]PYRIMIDINE-4,7-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS | |
| UA89787C2 (ru) | Фторгликозидные производные пиразолов, лекарственное средство, которое содержит их, и их применение | |
| ATE534650T1 (de) | Neue cyanothiazolide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| MEP58808A (en) | Dihydropteridinones, method for the production and use thereof in the form of drugs | |
| MEP39908A (en) | Novel anticholinergic agents that can be used as medicaments and method for the production thereof | |
| MEP42908A (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds | |
| HRP20050744A2 (en) | 4-(3-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivates and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis | |
| MA27232A1 (fr) | Derives d'acide n-benzoylureidocinnamique, leurs procedes de preparation et leurs utilisations | |
| DE50311923D1 (de) | Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| HRP20050715A2 (en) | Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof | |
| HRP20050667A2 (en) | Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof | |
| IL176914A0 (en) | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
| IL176915A0 (en) | Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
| HRP20050779A2 (en) | Supstituted benzoylureidopyridyl-piperidine and pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof | |
| BRPI0407212A (pt) | 2-aminoimidazóis substituìdos, processos para a sua preparação, sua aplicação como medicamento ou diagnóstico bem como o medicamento contendo os mesmos | |
| PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados | |
| TNSN06233A1 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
| ATE284394T1 (de) | Polycyclische thiazol-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20051221 Year of fee payment: 3 |
|
| A1OB | Publication of a patent application | ||
| OBST | Application withdrawn |